New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Could personalized neoantigen vaccines prevent the recurrence of pancreatic cancer and increase patient survival?

Could personalized neoantigen vaccines prevent the recurrence of pancreatic cancer and increase patient survival?

In a recent article published inNature, researchers conducted a phase I clinical trial of a personalized messenger ribonucleic acid (mRNA) neoantigen vaccine based on uridine mRNA–lipoplex nanop
World medicine November 23,2023
Could personalized neoantigen vaccines prevent the recurrence of pancreatic cancer and increase patient survival?

Could personalized neoantigen vaccines prevent the recurrence of pancreatic cancer and increase patient survival?

In a recent article published inNature, researchers conducted a phase I clinical trial of a personalized messenger ribonucleic acid (mRNA) neoantigen vaccine based on uridine mRNA–lipoplex nanop
World medicine November 23,2023
Millions are stuck in dental deserts, with no access to oral health care

Millions are stuck in dental deserts, with no access to oral health care

Every day, Adrienne Grimmett and her colleagues at Evara Health in the Tampa Bay area see stories of inequity in their patients' teeth, gums, and palates.Marked in painful abscesses, dangerous inf
World medicine November 23,2023
Millions are stuck in dental deserts, with no access to oral health care

Millions are stuck in dental deserts, with no access to oral health care

Every day, Adrienne Grimmett and her colleagues at Evara Health in the Tampa Bay area see stories of inequity in their patients' teeth, gums, and palates.Marked in painful abscesses, dangerous inf
World medicine November 23,2023
Trastuzumab Deruxtecan May Represent Potential Option for HER2-Expressing Solid Tumors

Trastuzumab Deruxtecan May Represent Potential Option for HER2-Expressing Solid Tumors

August 28, 2023Courtney FlahertyFunda Meric-Bernstam, MD, discusses the design of the DESTINY-PanTumor02 trial, details the antitumor activity and safety of T-DXd in HER2-expressing solid tumors, and
World medicine November 23,2023
Trastuzumab Deruxtecan May Represent Potential Option for HER2-Expressing Solid Tumors

Trastuzumab Deruxtecan May Represent Potential Option for HER2-Expressing Solid Tumors

August 28, 2023Courtney FlahertyFunda Meric-Bernstam, MD, discusses the design of the DESTINY-PanTumor02 trial, details the antitumor activity and safety of T-DXd in HER2-expressing solid tumors, and
World medicine November 23,2023
Montana considers requiring insurance to cover fertility preservation for cancer patients

Montana considers requiring insurance to cover fertility preservation for cancer patients

Katie Beall wasdiagnosed with breast canceron March 1, 2022. Two days later, doctors told her the chemotherapy she needed would make her infertile. The next day, she started looking into h
World medicine November 23,2023
Montana considers requiring insurance to cover fertility preservation for cancer patients

Montana considers requiring insurance to cover fertility preservation for cancer patients

Katie Beall wasdiagnosed with breast canceron March 1, 2022. Two days later, doctors told her the chemotherapy she needed would make her infertile. The next day, she started looking into h
World medicine November 23,2023
New AI tool accurately predicts aggressiveness of colorectal cancer

New AI tool accurately predicts aggressiveness of colorectal cancer

A new artificial intelligence model designed by researchers at Harvard Medical School and National Cheng Kung University in Taiwan could bring much-needed clarity to doctors delivering prognoses and d
World medicine November 23,2023
New AI tool accurately predicts aggressiveness of colorectal cancer

New AI tool accurately predicts aggressiveness of colorectal cancer

A new artificial intelligence model designed by researchers at Harvard Medical School and National Cheng Kung University in Taiwan could bring much-needed clarity to doctors delivering prognoses and d
World medicine November 23,2023
Matching-Adjusted Analysis Shows Acalabrutinib/Obinutuzumab Offers PFS Benefit Vs Zanubrutinib in CLL/SLL Without 17p Deletion

Matching-Adjusted Analysis Shows Acalabrutinib/Obinutuzumab Offers PFS Benefit Vs Zanubrutinib in CLL/SLL Without 17p Deletion

October 10, 2023Kyle DohertyPatients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic leukemia without 17p deletions experienced superior efficacy following treatment with acalabrut
World medicine November 23,2023
Matching-Adjusted Analysis Shows Acalabrutinib/Obinutuzumab Offers PFS Benefit Vs Zanubrutinib in CLL/SLL Without 17p Deletion

Matching-Adjusted Analysis Shows Acalabrutinib/Obinutuzumab Offers PFS Benefit Vs Zanubrutinib in CLL/SLL Without 17p Deletion

October 10, 2023Kyle DohertyPatients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic leukemia without 17p deletions experienced superior efficacy following treatment with acalabrut
World medicine November 23,2023
Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.One pote
World medicine November 23,2023
Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.One pote
World medicine November 23,2023
Pembrolizumab Plus Enzalutamide Delivers No rPFS or OS Benefits in mCRPC

Pembrolizumab Plus Enzalutamide Delivers No rPFS or OS Benefits in mCRPC

October 22, 2023Kristie L. KahlPembrolizumab plus enzalutamide provided no radiographic progression-free survival or overall survival improvements vs enzalutamide alone in patients with metastatic cas
World medicine November 23,2023
Pembrolizumab Plus Enzalutamide Delivers No rPFS or OS Benefits in mCRPC

Pembrolizumab Plus Enzalutamide Delivers No rPFS or OS Benefits in mCRPC

October 22, 2023Kristie L. KahlPembrolizumab plus enzalutamide provided no radiographic progression-free survival or overall survival improvements vs enzalutamide alone in patients with metastatic cas
World medicine November 23,2023
Changes to tumor DNA can help predict cancer's next move

Changes to tumor DNA can help predict cancer's next move

Knowing whether a tumor might grow or spread to other parts of a patient’s body could be key to survival – and now scientists are one step closer to unlocking the ability to predict just that.In a ser
World medicine November 23,2023
Changes to tumor DNA can help predict cancer's next move

Changes to tumor DNA can help predict cancer's next move

Knowing whether a tumor might grow or spread to other parts of a patient’s body could be key to survival – and now scientists are one step closer to unlocking the ability to predict just that.In a ser
World medicine November 23,2023
Adjuvant Nivolumab Approved in Europe for Completely Resected Stage IIB or IIC Melanoma

Adjuvant Nivolumab Approved in Europe for Completely Resected Stage IIB or IIC Melanoma

August 22, 2023Kristi RosaThe European Commission has approved single-agent nivolumab for use in the adjuvant treatment of adult and adolescent patients aged 12 years or older who have stage IIB or II
World medicine November 23,2023
Adjuvant Nivolumab Approved in Europe for Completely Resected Stage IIB or IIC Melanoma

Adjuvant Nivolumab Approved in Europe for Completely Resected Stage IIB or IIC Melanoma

August 22, 2023Kristi RosaThe European Commission has approved single-agent nivolumab for use in the adjuvant treatment of adult and adolescent patients aged 12 years or older who have stage IIB or II
World medicine November 23,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com